Combination of FXR Agonist MET642 With Tofacitinib Exhibits Synergistic Effects in Improving Colitis in Adoptive T-Cell Transfer IBD Model

Back
Poster presentation at DDW – Digestive Disease Week, May 2021

Download PDF